Title:
TYK2 SELECTIVE INHIBITOR AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2022/242697
Kind Code:
A1
Abstract:
A compound represented by formula (I), or a tautomer, mesomer, racemate, enantiomer or diastereomer thereof or a pharmaceutically acceptable salt thereof, and a use thereof for preparing a drug for treating TYK2-mediated diseases.
Inventors:
WANG LISHA (CN)
CHEN HONGDAO (CN)
WANG LIN (CN)
WANG JIE (CN)
LI JIN (CN)
ZHAO SHUHAI (CN)
YANG MINMIN (CN)
CHEN HONGDAO (CN)
WANG LIN (CN)
WANG JIE (CN)
LI JIN (CN)
ZHAO SHUHAI (CN)
YANG MINMIN (CN)
Application Number:
PCT/CN2022/093719
Publication Date:
November 24, 2022
Filing Date:
May 19, 2022
Export Citation:
Assignee:
PHARMABLOCK SCIENCES NANJING INC (CN)
International Classes:
C07D471/04; A61K31/407; A61K31/437; A61P31/18; A61P35/00; C07D487/04
Domestic Patent References:
| WO2019178079A1 | 2019-09-19 | |||
| WO2020020288A1 | 2020-01-30 | |||
| WO2014026327A1 | 2014-02-20 | |||
| WO2018234354A1 | 2018-12-27 |
Foreign References:
| CN102311448A | 2012-01-11 |
Attorney, Agent or Firm:
BEYOND ATTORNEYS AT LAW (CN)
Download PDF:
Previous Patent: ARGININE METHYLTRANSFERASE INHIBITOR AND USE THEREOF
Next Patent: DISCHARGE GROUNDING PROTECTION DEVICE FOR DRY-TYPE TRANSFORMER
Next Patent: DISCHARGE GROUNDING PROTECTION DEVICE FOR DRY-TYPE TRANSFORMER